AAPL352.78-3.49 (-0.98%) ▼|ABBV294.55-0.48 (-0.16%) ▼|ABT107.45-1.07 (-0.99%) ▼|ACN247.70-2.79 (-1.11%) ▼|ADBE246.00+2.92 (+1.20%) ▲|AMAT350.25-20.25 (-5.47%) ▼|AMD504.28-29.78 (-5.58%) ▼|AMGN462.32-3.35 (-0.72%) ▼|AMT190.74-0.90 (-0.47%) ▼|AMZN257.75-8.91 (-3.34%) ▼|AVGO333.40-13.61 (-3.92%) ▼|AXP319.05-1.55 (-0.48%) ▼|BA165.22-6.28 (-3.66%) ▼|BAC50.08-0.94 (-1.84%) ▼|BKNG157.53-2.05 (-1.28%) ▼|BLK1,197.97-24.94 (-2.04%) ▼|BMY62.93-0.50 (-0.79%) ▼|BNY151.69-1.72 (-1.12%) ▼|BRK-B592.85-0.09 (-0.02%) ▼|C121.32-2.69 (-2.17%) ▼|CAT570.49-29.71 (-4.95%) ▼|CL100.99+1.32 (+1.32%) ▲|CMCSA25.60+0.44 (+1.75%) ▲|COF193.22-1.06 (-0.55%) ▼|COP140.52-0.83 (-0.59%) ▼|COST1,113.74+7.53 (+0.68%) ▲|CRM214.83-3.01 (-1.38%) ▼|CSCO94.52-1.12 (-1.17%) ▼|CVS88.59-0.76 (-0.85%) ▼|CVX217.14-2.75 (-1.25%) ▼|DE653.99-19.55 (-2.90%) ▼|DHR229.91-3.11 (-1.33%) ▼|DIS118.70-0.27 (-0.23%) ▼|DUK130.59+1.43 (+1.11%) ▲|EMR160.65-5.73 (-3.44%) ▼|FDX327.65+3.51 (+1.08%) ▲|GD359.69-3.77 (-1.04%) ▼|GE325.18-6.63 (-2.00%) ▼|GEV763.57-39.56 (-4.93%) ▼|GILD167.58-0.50 (-0.30%) ▼|GM83.67-2.33 (-2.71%) ▼|GOOG281.26-11.26 (-3.85%) ▼|GOOGL283.72-12.05 (-4.07%) ▼|GS891.54-25.02 (-2.73%) ▼|HD347.51-1.18 (-0.34%) ▼|HON217.95-4.51 (-2.03%) ▼|IBM242.51-4.62 (-1.87%) ▼|INTC55.47-4.19 (-7.02%) ▼|INTU345.56+3.86 (+1.13%) ▲|ISRG437.75-5.84 (-1.32%) ▼|JNJ282.55-3.20 (-1.12%) ▼|JPM338.21-7.98 (-2.31%) ▼|KO99.48+0.23 (+0.23%) ▲|LIN523.46-2.60 (-0.49%) ▼|LLY1,431.67-11.83 (-0.82%) ▼|LMT585.21-10.83 (-1.82%) ▼|LOW224.93-2.80 (-1.23%) ▼|LRCX210.83-15.09 (-6.68%) ▼|MA661.71+0.52 (+0.08%) ▲|MCD274.67+2.70 (+0.99%) ▲|MDLZ67.54+0.00 (+0.00%) ▲|MDT102.88+0.02 (+0.02%) ▲|META626.41-15.28 (-2.38%) ▼|MMM181.68-1.98 (-1.08%) ▼|MO78.90+0.26 (+0.33%) ▲|MRK144.46-3.30 (-2.23%) ▼|MS185.57-5.08 (-2.66%) ▼|MSFT517.99-5.89 (-1.12%) ▼|MU719.02-59.29 (-7.62%) ▼|NEE85.34+0.22 (+0.26%) ▲|NFLX60.75-1.40 (-2.25%) ▼|NKE38.26+0.27 (+0.71%) ▲|NOW99.37-2.88 (-2.82%) ▼|NVDA156.14-6.71 (-4.12%) ▼|ORCL119.09-6.26 (-4.99%) ▼|PEP146.43+0.99 (+0.68%) ▲|PFE28.86-0.03 (-0.10%) ▼|PG173.02+3.22 (+1.90%) ▲|PLTR160.39-7.60 (-4.52%) ▼|PM196.04-2.92 (-1.47%) ▼|QCOM168.52-3.95 (-2.29%) ▼|RTX194.89-3.69 (-1.86%) ▼|SBUX108.72+2.28 (+2.14%) ▲|SCHW92.94-0.04 (-0.04%) ▼|SO94.64+1.81 (+1.95%) ▲|SPG232.78-0.19 (-0.08%) ▼|T22.36+0.18 (+0.81%) ▲|TMO691.33-8.89 (-1.27%) ▼|TMUS170.01+0.06 (+0.04%) ▲|TSLA379.74-10.48 (-2.69%) ▼|TXN294.21-9.39 (-3.09%) ▼|UBER69.99+0.30 (+0.43%) ▲|UNH412.02+4.56 (+1.12%) ▲|UNP303.71+1.27 (+0.42%) ▲|UPS111.82+1.06 (+0.96%) ▲|USB60.43-0.56 (-0.92%) ▼|V426.46+0.70 (+0.16%) ▲|VZ46.34-0.02 (-0.04%) ▼|WFC84.84-1.21 (-1.41%) ▼|WMT128.41+0.32 (+0.25%) ▲|XOM166.87-2.65 (-1.56%) ▼|AAPL352.78-3.49 (-0.98%) ▼|ABBV294.55-0.48 (-0.16%) ▼|ABT107.45-1.07 (-0.99%) ▼|ACN247.70-2.79 (-1.11%) ▼|ADBE246.00+2.92 (+1.20%) ▲|AMAT350.25-20.25 (-5.47%) ▼|AMD504.28-29.78 (-5.58%) ▼|AMGN462.32-3.35 (-0.72%) ▼|AMT190.74-0.90 (-0.47%) ▼|AMZN257.75-8.91 (-3.34%) ▼|AVGO333.40-13.61 (-3.92%) ▼|AXP319.05-1.55 (-0.48%) ▼|BA165.22-6.28 (-3.66%) ▼|BAC50.08-0.94 (-1.84%) ▼|BKNG157.53-2.05 (-1.28%) ▼|BLK1,197.97-24.94 (-2.04%) ▼|BMY62.93-0.50 (-0.79%) ▼|BNY151.69-1.72 (-1.12%) ▼|BRK-B592.85-0.09 (-0.02%) ▼|C121.32-2.69 (-2.17%) ▼|CAT570.49-29.71 (-4.95%) ▼|CL100.99+1.32 (+1.32%) ▲|CMCSA25.60+0.44 (+1.75%) ▲|COF193.22-1.06 (-0.55%) ▼|COP140.52-0.83 (-0.59%) ▼|COST1,113.74+7.53 (+0.68%) ▲|CRM214.83-3.01 (-1.38%) ▼|CSCO94.52-1.12 (-1.17%) ▼|CVS88.59-0.76 (-0.85%) ▼|CVX217.14-2.75 (-1.25%) ▼|DE653.99-19.55 (-2.90%) ▼|DHR229.91-3.11 (-1.33%) ▼|DIS118.70-0.27 (-0.23%) ▼|DUK130.59+1.43 (+1.11%) ▲|EMR160.65-5.73 (-3.44%) ▼|FDX327.65+3.51 (+1.08%) ▲|GD359.69-3.77 (-1.04%) ▼|GE325.18-6.63 (-2.00%) ▼|GEV763.57-39.56 (-4.93%) ▼|GILD167.58-0.50 (-0.30%) ▼|GM83.67-2.33 (-2.71%) ▼|GOOG281.26-11.26 (-3.85%) ▼|GOOGL283.72-12.05 (-4.07%) ▼|GS891.54-25.02 (-2.73%) ▼|HD347.51-1.18 (-0.34%) ▼|HON217.95-4.51 (-2.03%) ▼|IBM242.51-4.62 (-1.87%) ▼|INTC55.47-4.19 (-7.02%) ▼|INTU345.56+3.86 (+1.13%) ▲|ISRG437.75-5.84 (-1.32%) ▼|JNJ282.55-3.20 (-1.12%) ▼|JPM338.21-7.98 (-2.31%) ▼|KO99.48+0.23 (+0.23%) ▲|LIN523.46-2.60 (-0.49%) ▼|LLY1,431.67-11.83 (-0.82%) ▼|LMT585.21-10.83 (-1.82%) ▼|LOW224.93-2.80 (-1.23%) ▼|LRCX210.83-15.09 (-6.68%) ▼|MA661.71+0.52 (+0.08%) ▲|MCD274.67+2.70 (+0.99%) ▲|MDLZ67.54+0.00 (+0.00%) ▲|MDT102.88+0.02 (+0.02%) ▲|META626.41-15.28 (-2.38%) ▼|MMM181.68-1.98 (-1.08%) ▼|MO78.90+0.26 (+0.33%) ▲|MRK144.46-3.30 (-2.23%) ▼|MS185.57-5.08 (-2.66%) ▼|MSFT517.99-5.89 (-1.12%) ▼|MU719.02-59.29 (-7.62%) ▼|NEE85.34+0.22 (+0.26%) ▲|NFLX60.75-1.40 (-2.25%) ▼|NKE38.26+0.27 (+0.71%) ▲|NOW99.37-2.88 (-2.82%) ▼|NVDA156.14-6.71 (-4.12%) ▼|ORCL119.09-6.26 (-4.99%) ▼|PEP146.43+0.99 (+0.68%) ▲|PFE28.86-0.03 (-0.10%) ▼|PG173.02+3.22 (+1.90%) ▲|PLTR160.39-7.60 (-4.52%) ▼|PM196.04-2.92 (-1.47%) ▼|QCOM168.52-3.95 (-2.29%) ▼|RTX194.89-3.69 (-1.86%) ▼|SBUX108.72+2.28 (+2.14%) ▲|SCHW92.94-0.04 (-0.04%) ▼|SO94.64+1.81 (+1.95%) ▲|SPG232.78-0.19 (-0.08%) ▼|T22.36+0.18 (+0.81%) ▲|TMO691.33-8.89 (-1.27%) ▼|TMUS170.01+0.06 (+0.04%) ▲|TSLA379.74-10.48 (-2.69%) ▼|TXN294.21-9.39 (-3.09%) ▼|UBER69.99+0.30 (+0.43%) ▲|UNH412.02+4.56 (+1.12%) ▲|UNP303.71+1.27 (+0.42%) ▲|UPS111.82+1.06 (+0.96%) ▲|USB60.43-0.56 (-0.92%) ▼|V426.46+0.70 (+0.16%) ▲|VZ46.34-0.02 (-0.04%) ▼|WFC84.84-1.21 (-1.41%) ▼|WMT128.41+0.32 (+0.25%) ▲|XOM166.87-2.65 (-1.56%) ▼|
11.5 C
New York
Monday, November 16, 2026

Tag: development

Armada Hoffler Announces A. Russell Kirk Will Retire From The Company’s Board Of Directors

Kirk has been a key figure at Armada Hoffler for over 40 years
Kirk has been a key figure at Armada Hoffler for over 40 years

Inceptio Technology Joins the Autoware Foundation to Accelerate Autonomous Driving Technologies for Trucks

SHANGHAI, June 18, 2025 /PRNewswire/ -- Inceptio Technology ("Inceptio" or the "Company"), an industry leading developer of autonomous truck technologies, today announced that it has...

TOLREMO therapeutics Announces Strengthening of Leadership: Alessandra Cesano Joins Board of Directors, Florian D. Vogl Appointed Chief Medical Officer

Basel, Switzerland – June 18, 2025 - TOLREMO therapeutics AG (TOLREMO), a clinical-stage biotechnology company developing TT125-802, a best-in-class CBP/p300 bromodomain inhibitor for the treatment of solid tumors and multiple myeloma, today announced key leadership appointments. Alessandra Cesano, MD, PhD, who has served as Consulting Chief Medical Officer since April 2023, will join the company’s Board of Directors. Florian D. Vogl, MD, PhD, has been appointed as Chief Medical Officer (CMO), succeeding Alessandra Cesano on the executive team.

Leoch Battery to Showcase Full Scenarios Smart Energy Solutions at The Battery Show Asia 2025

HONG KONG, June 18, 2025 /PRNewswire/ -- The Battery Show Asia (TBSA), Asia's flagship exhibition for battery, energy storage and e-mobility technologies, will make...

Autogun Heroes: Supercharged launches on Steam

Relive the fast-paced action and nostalgic thrills of retro gaming in this new game Autogun Heroes: Supercharged KOTKA, Finland, June 18, 2025 /PRNewswire/ -- Nitro Games announces...

Rewind Therapeutics Strengthens Scientific Advisory Board with Leading International Neurology Experts as it Advances First-in-Class Remyelination Therapy

Professors Shiv Saidha, Cristina Granziera, David Leppert, and Roberto Furlan are world-renowned experts in neuroimaging, multiple sclerosis (MS) biomarkers, neuroimmunology, and translational drug developmentAppointments...

Camurus’ POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

CAM2029 reduces liver and cyst volume growth compared to placebo Well tolerated with no new or unexpected safety findingsA follow-up Phase 3 study will be...

Novo Holdings Reports Strong Momentum in Asia Across Healthcare and Planetary Health in 2024

Landmark investments, portfolio progress, and expanded presence positionNovo Holdings for long-term growth and impact in Asia SINGAPORE, June 18, 2025 /PRNewswire/ -- Novo Holdings today released...

Business aviation leader Luxaviation and Haffner Energy join forces to accelerate SAF production and promotion

Business aviation leader Luxaviation and Haffner Energy join forces to accelerate SAF production and promotion

China Cycle Releases 2025 International Bicycle Exhibition Analysis Report

SHANGHAI, June 18, 2025 (GLOBE NEWSWIRE) -- The 33rd China International Bicycle Fair (CHINA CYCLE 2025 in abbreviation), with the theme “New Quality Productivity for the Shared Future”, has been grandly held from May 5th to 8th, 2025 at Shanghai New International Expo Center. This exhibition keeps pace with the times and has once again achieved breakthroughs in scale and content, creating a diverse and colorful display environment for exhibitors, buyers and visitors. The service quality of the exhibition has also been improved, and a more complete international bicycle industry trade platform has been built. Chinese and foreign mainstream media and industry media, including CCTV and Xinhuanet, have reported on the CHINA CYCLE.

Oncoinvent Announces Positive Final Data from Phase 1/2a Trial of Radspherin® in Patients with Colorectal Peritoneal Metastases

Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO, Norway, June...

80 years of Sennheiser: Eight decades full of emotion, innovation and passion for audio

SINGAPORE, June 18, 2025 /PRNewswire/ -- Since 1945, the name Sennheiser has stood for pioneering audio technology and passionate engineering. This year, the company...

Net asset value of the EfTEN United Property Fund as of 31.05.2025

EfTEN United Property Fund earned a net profit of 170 thousand euros in May and 1,32 million euros in the first five months of 2025 (compared to 357 thousand euros in the same time last year). In May, the fund made a cash distribution to investors in the amount of 1.47 million euros, or 57-euro cents per unit. As a result, the fund's net asset value (NAV) decreased by 4,4% and was 11,02 euros per unit at the end of May. Without the distribution the NAV of EfTEN United Property Fund would have increased by 0,6% in May.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevelopment